Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
Clinical trial NCT06870942 · RECRUITING
Trial details
- NCT number
- NCT06870942
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-28
- Primary completion
- 2024-11-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.